Urban Black gay, and bisexual men (MSM) bear a disproportionate burden of HIV in the U.S. Mental health is a barrier to adherence to both antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP). The objective was to determine the association between psychological distress and ART or PrEP adherence among urban Black MSM.
Methods
Using data from a four-year prospective cohort study, adherence to ART was defined as > 95% and PrEP was defined as > 80% of doses taken in the past 30 days. Psychological distress measures included difficulty sleeping; feeling anxious; suicidality; feeling sad or depressed; feeling sick, ill, or not well in the past 3 months; high (vs. low) overall psychological distress was classified as above the median value. Associations were examined using Chi-square, Fisher’s exact tests, and logistic regression.
Results
Among 165 Black MSM, 44.2% (73) reported high psychological distress. 65.3% (47/72) of participants living with HIV and 39.8% (37/93) of HIV negative participants were ART or PrEP adherent, respectively. Education was significantly associated with PrEP adherence (p = 0.038). Non-injection drug use in the past 3 months (p = 0.008), difficulty sleeping (p = 0.010), feeling anxious (p = 0.003), and feeling sad or depressed (p < 0.001), and overall psychological distress (p < 0.001) were significantly associated with ART adherence. High psychological distress was significantly associated with a reduced odds of ART adherence (aOR 0.23; 95% CI = 0.08–0.70) adjusting for age and non-injection drug use.
Conclusions
Increased psychological distress was significantly associated with ART nonadherence and may represent an important barrier to viral suppression.
KimJLeeEParkBJ, et al.Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: A nationwide study. Sci Rep2018; 8: 3133.
KannyDJeffriesWL IVChapin-BardalesJ, et al.Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men — 23 Urban Areas, 2017. MMWR Morb Mortal Wkly Rep2019; 68: 801–806.
van EppsPMaierMLundB, et al.Medication adherence in a nationwide cohort of veterans initiating pre-exposure prophylaxis (PrEP) to prevent HIV infection. JAIDS2018; 77(3): 272–278.
HojillaJCHurleyLBMarcusJL, et al.Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among us adults in an integrated health care system. JAMA Netw Open2021; 4(8): e2122692.
17.
ShubberZMillsEJNachegaJB, et al.Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med2016; 13(11): e1002183.
18.
MayerKHAgwuAMalebrancheD. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther2020; 37(5): 1778–1811.
19.
NelAKageeA. Common mental health problems and antiretroviral therapy adherence. AIDS Care2011; 23(11): 1360–1365.
20.
MillerSJHarrisonSESanasi-BholaK. A scoping review investigating relationships between depression, anxiety, and the PrEP care continuum in the United States. Int J Environ Res Public Health2021; 18(21): 11431.
21.
YoungLBLalley-ChareczkoLClarkD, et al.Correlation of pre-exposure prophylaxis adherence to a mental health diagnosis or experience of childhood trauma in high-risk youth. Intl J STD AIDS2020; 31(5): 440–446.
22.
GibbieTMMijchAHayM. High levels of psychological distress in MSM are independent of HIV status. J Health Psychol2012; 17(5): 653–663.
23.
JenningsJMWagnerJTilchinC, et al.Methamphetamine use, syphilis and specific online sex partner meeting venues are associated with HIV among urban black gay and bisexual men who have sex men. Sex Transm Dis2021; 48(8S): S32–S39.
24.
SchumacherCMTaoXChandranA, et al.Reaching those most at risk for HIV acquisition: evaluating racial/ethnic disparities in the preexposure prophylaxis care continuum in Baltimore City, Maryland. J Acquir Immune Defic Syndr2021; 87(5): 1145–1153.
25.
DíazRMAyalaGBeinE. Sexual risk as an outcome of social oppression: data from a probability sample of Latino gay men in three U.S. cities. Cultur Divers Ethnic Minor Psychol2004; 10(3): 255–267.
26.
MthembuJCMabasoMLHKhanG, et al.Prevalence of psychological distress and its association with socio-demographic and HIV-risk factors in South Africa: findings of the 2012 HIV prevalence, incidence and behaviour survey. SSM Popul Health2017; 3: 658–662.
27.
SpaanPvan LuenenSGarnefskiN, et al.Psychosocial interventions enhance HIV medication adherence: a systematic review and meta-analysis. J Health Psychol2020; 25(10-11): 1326–1340.
28.
DillardPKZunigaJAHolstadMM. An integrative review of the efficacy of motivational interviewing in HIV management. Patient Educ Couns2017; 100(4): 636–646.
29.
NanceRMDelaneyJACSimoniJM, et al.HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med2018; 169: 376–384.
30.
BeerLMattsonCLBradleyH, et al.Understanding cross-sectional racial, ethnic, and gender disparities in antiretroviral use and viral suppression among HIV patients in the United States. Medicine (Baltimore)2016; 95: e3171.
31.
SimoniJMHuhDWilsonIB, et al.Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr2012; 60: 466–472.
32.
SullivanPSSatcher JohnsonAPembletonES, et al.Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet2021; 397(10279): 1095–1106.
33.
TilchinCWagnerJSchumacherCM, et al.HIV transmission potential and sex partner concurrency: evidence for racial disparities in HIV risk among gay and bisexual men (MSM). AIDS Behav2022; 26(3): 709–718.
